This has been subsequently supported by studies documenting recurrent MYCC de-regulation in human tumors, from animal models of Myc over-expression and from demonstrations that Myc silencing in these models promotes tumor regression [2, 3]. The gene discussed is MYC; the disease is neoplasm.